Show simple item record

dc.contributor.authorLee, Rebecca J
dc.contributor.authorRothwell, Dominic G
dc.contributor.authorJackson, R.
dc.contributor.authorSmith, N.
dc.contributor.authorWong, S. Q.
dc.contributor.authorKelso, N.
dc.contributor.authorBurghel, G.
dc.contributor.authorHewitt, C.
dc.contributor.authorClarke, H.
dc.contributor.authorMitchell, J.
dc.contributor.authorJones, K.
dc.contributor.authorMuinonen-Martin, A.
dc.contributor.authorTurajlic, S.
dc.contributor.authorCorrie, P. G.
dc.contributor.authorMarais, Richard
dc.contributor.authorMiddleton, M. R.
dc.contributor.authorDawson, S. J.
dc.contributor.authorSandhu, S.
dc.contributor.authorDive, Caroline
dc.contributor.authorLorigan, Paul C
dc.date.accessioned2022-11-30T10:21:33Z
dc.date.available2022-11-30T10:21:33Z
dc.date.issued2022en
dc.identifier.citationLee R, Rothwell DG, Jackson R, Smith N, Wong SQ, Kelso N, et al. DETECTION phase II/III trial: Circulating tumor DNA-guided therapy for stage IIB/C melanoma after surgical resection. Journal of Clinical Oncology. 2022 Jun;40(16). PubMed PMID: WOS:000863680305159.en
dc.identifier.doi10.1200/JCO.2022.40.16_suppl.TPS9603en
dc.identifier.urihttp://hdl.handle.net/10541/625836
dc.titleDETECTION phase II/III trial: Circulating tumor DNA-guided therapy for stage IIB/C melanoma after surgical resectionen
dc.typeMeetings and Proceedingsen
dc.contributor.departmentThe Christie NHS Foundation Trust, Manchester,en
dc.identifier.journalJournal of Clinical Oncologyen
dc.description.noteen]


This item appears in the following Collection(s)

Show simple item record